[go: up one dir, main page]

CN111999270A - An exosome detection method based on whispering gallery mode optical microcavity - Google Patents

An exosome detection method based on whispering gallery mode optical microcavity Download PDF

Info

Publication number
CN111999270A
CN111999270A CN202010526595.XA CN202010526595A CN111999270A CN 111999270 A CN111999270 A CN 111999270A CN 202010526595 A CN202010526595 A CN 202010526595A CN 111999270 A CN111999270 A CN 111999270A
Authority
CN
China
Prior art keywords
microcavity
aptamer
exosome
carboxyl
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010526595.XA
Other languages
Chinese (zh)
Inventor
王秀红
索明倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing University of Technology
Original Assignee
Beijing University of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing University of Technology filed Critical Beijing University of Technology
Priority to CN202010526595.XA priority Critical patent/CN111999270A/en
Publication of CN111999270A publication Critical patent/CN111999270A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

一种基于回音壁模式通过检测细胞分泌物来进行对细胞内物质检测的方法,属于激光技术与生物医学领域的交叉领域。方法包括以下几点:(1)回音壁微腔的选取;(2)微腔的表面处理选择;(3)微腔与待测细胞分泌物外泌体的识别探测方法。本发明检测灵敏度高,能够在细胞外实现高效识别检测。回音壁模式使荧光在腔内形成谐振,产生激光,实现了延长跟踪检测时间并根据增强的检测信号实现跟踪识别的功能。

Figure 202010526595

A method for detecting intracellular substances by detecting cell secretions based on a whispering gallery mode belongs to the cross field of laser technology and biomedicine. The method includes the following points: (1) the selection of the whispering gallery microcavity; (2) the selection of the surface treatment of the microcavity; (3) the identification and detection method of the microcavity and the exosomes secreted by the cells to be tested. The invention has high detection sensitivity and can realize high-efficiency identification and detection outside the cell. The whispering gallery mode makes the fluorescence resonate in the cavity to generate laser light, which realizes the function of prolonging the tracking detection time and realizing the tracking and identification function according to the enhanced detection signal.

Figure 202010526595

Description

一种基于回音壁模式光学微腔的外泌体检测方法An exosome detection method based on whispering gallery mode optical microcavity

技术领域technical field

本发明是一种利用回音壁模式的微腔对细胞分泌物外泌体进行检测,主要涉及的技术包括细胞激光器原理和外泌体与微腔的检测识别方法,属于激光技术与生物医学光子学领域。The invention is a microcavity of the whispering gallery mode to detect cell secretion exosomes. The technology mainly involves the principle of cell laser and the detection and identification method of exosomes and microcavities, belonging to laser technology and biomedical photonics. field.

背景技术Background technique

回音壁模式光学微腔(微球腔,微环腔,微盘腔等),具有极小的模式体积,超高Q值、超高的能量密度和极窄的线宽等优越特性,因此成为最有发展潜力的光学器件之一。微腔作为一种特殊的光学谐振腔,当激光耦合进微腔内部时,且在满足全反射和相位匹配的条件下,光信号在微腔内通过边界连续全反射,将光子长时间的局域在微腔内形成回音壁模式的介质谐振腔,在外界激励下当增益大于损耗时,就会输出新的波段激光信号。Whispering gallery mode optical microcavity (microsphere cavity, microring cavity, microdisk cavity, etc.) has excellent characteristics such as extremely small mode volume, ultra-high Q value, ultra-high energy density and extremely narrow linewidth, so it has become the most advanced optical microcavity. One of the optical devices with development potential. As a special optical resonator, when the laser is coupled into the microcavity, and under the conditions of total reflection and phase matching, the optical signal is continuously and totally reflected by the boundary in the microcavity, and the photons are localized for a long time. When the gain is greater than the loss under external excitation, a new waveband laser signal will be output.

光学微腔因其微小,灵敏等优点广泛应用于生物传感和检测。检测原理是光耦合进微腔中满足谐振条件,在微腔表面发生全反射形成约200nm的倏逝波,当微腔与待测物结合时,微腔内部的光运动轨道长度会增加且周围折射率也会发生变化,不同物质导致折射率发生的变化不同,此时即可通过波谱的位移来确定待测物的存在。Optical microcavities are widely used in biological sensing and detection due to their small size and sensitivity. The detection principle is that light is coupled into the microcavity to satisfy the resonance condition, and a total reflection occurs on the surface of the microcavity to form an evanescent wave of about 200 nm. The refractive index will also change. Different substances cause different changes in the refractive index. At this time, the existence of the object to be tested can be determined by the shift of the spectrum.

外泌体属于细胞分泌物,由脂质双层包围的细胞外囊泡,尺寸为 20-170nm,包含蛋白质和核酸。且除了自身携带标记蛋白和反映细胞来源的组织或细胞类型特异性蛋白外,还含有各种mRNA、microRNA 及siRNAs等。它们由所有细胞分泌并广泛的存在于体液中,其中包括血液、泪液、唾液、尿液、乳汁、脑脊液和腹液等。因此关于对外泌体的检测发现,有助于对人类生命体的探索发现。Exosomes are cell secretions, extracellular vesicles surrounded by lipid bilayers, 20-170 nm in size, and contain proteins and nucleic acids. In addition to self-carried marker proteins and tissue- or cell-type-specific proteins that reflect cell origin, it also contains various mRNAs, microRNAs, and siRNAs. They are secreted by all cells and widely present in body fluids, including blood, tears, saliva, urine, breast milk, cerebrospinal fluid, and abdominal fluid. Therefore, the detection and discovery of exosomes is helpful for the exploration and discovery of human life.

当光束在微腔内壁发生全反射行走一圈的光程是波长的整数倍时候,会发生共振现象,将谐振光子长时间的限制在微米尺度,也就使得谐振模式范围内的物质与光子多次发生相互作用。2016年,Frank Vollmer小组基于回音壁模式的微球腔与金纳米棒的等离激元谐振耦合,通过回音壁谐振频率用移动成功在水溶液中检测到单个原子离子。When the total reflection of the light beam on the inner wall of the microcavity travels around an optical path that is an integer multiple of the wavelength, a resonance phenomenon will occur, confining the resonant photons to the micrometer scale for a long time, which means that there are more substances and photons within the resonant mode range. interaction occurs. In 2016, Frank Vollmer's group successfully detected single atomic ions in aqueous solution by shifting the whispering gallery resonance frequency based on the microsphere cavity of the whispering gallery mode and the plasmon resonance coupling of gold nanorods.

本发明是基于此背景产生的。The present invention is based on this background.

发明内容SUMMARY OF THE INVENTION

本发明是一种基于回音壁模式通过检测细胞分泌物外泌体来进行细胞探索的方法属于激光技术与生物医学领域的交叉领域。方法包括以下几点:(1)回音壁微腔的选取;(2)微腔的表面修饰选择;(3) 微腔与待测细胞外泌体的识别探测方法。本发明可通过纳米级的激发波长位移变化实现高灵敏度检测,能够在细胞外进行识别检测。回音壁模式使荧光在腔内形成谐振,产生激光,延长了跟踪检测时间并根据增强的检测信号实现跟踪识别的功能。The invention is a method for cell exploration by detecting cell secretion exosomes based on the whispering gallery mode, which belongs to the cross field of laser technology and biomedicine. The method includes the following points: (1) the selection of the whispering gallery microcavity; (2) the surface modification selection of the microcavity; (3) the identification and detection method of the microcavity and the cell exosomes to be tested. The present invention can realize high-sensitivity detection through nanoscale excitation wavelength shift changes, and can perform identification and detection outside cells. The whispering gallery mode makes the fluorescence resonate in the cavity to generate laser light, which prolongs the tracking detection time and realizes the tracking and identification function according to the enhanced detection signal.

具体包括以下步骤:Specifically include the following steps:

步骤1:该实验所使用的微腔可以为微球腔、微环腔、微盘腔、等固态微腔,微腔的制作材料可以是传播损耗较小的硅类化合物、无定型玻璃材料和聚合物材料等,通过高温熔融和溶胶凝胶法制备微腔。在微腔内可以选择掺杂染料、量子点、荧光蛋白等其中的一种荧光物质。用符合相应条件波长的激光耦合进微腔内形成谐振,达到阈值条件时激发出激光。Step 1: The microcavity used in this experiment can be a solid microcavity such as a microsphere cavity, a microring cavity, a microdisk cavity, etc. The fabrication material of the microcavity can be a silicon compound with a small propagation loss, an amorphous glass material, and a polymer. materials, etc., microcavities are prepared by high-temperature melting and sol-gel methods. In the microcavity, one of the fluorescent substances such as dyes, quantum dots, fluorescent proteins, etc. can be selected to be doped. The laser with the wavelength that meets the corresponding conditions is coupled into the microcavity to form resonance, and the laser is excited when the threshold condition is reached.

步骤2:将荧光微腔表面进行功能化处理,购买羧基修饰或氨基修饰的荧光微腔,然后与氨基或者羧基修饰的适体或者特异性抗体蛋白经过氨基和羧基的共价偶联的结合,从而使荧光微腔可以特异性识别待检测的不同细胞的外泌体。Step 2: Functionalize the surface of the fluorescent microcavity, purchase carboxyl-modified or amino-modified fluorescent microcavities, and then combine with amino- or carboxyl-modified aptamers or specific antibody proteins through covalent coupling between amino and carboxyl groups, Thus, the fluorescent microcavity can specifically identify the exosomes of different cells to be detected.

步骤3:将修饰羧基或氨基的荧光微腔与能够和相应的细胞外泌体发生特异性结合的氨基或者羧基修饰的适体或特异性抗体蛋白进行共价偶联。经过2-4小时,羧基或者氨基修饰的荧光微腔与氨基或者羧基修饰的适体发生特异性识别,氨基羧基经脱水缩合反应连接在一起;将连接好的微腔-适体与相应的细胞提取的外泌体一起孵育0.5 个小时,适体与相应的外泌体的表面发生特异性识别并结合。或者将购买的修饰了具有特异性识别外泌体外表抗原的抗体的荧光微腔与外泌体进行混合孵育0.5小时,通过共聚焦检测验证连接成功后接下来用激光器照射微球。激发荧光耦合进微球内产生回音壁模式下的激光,外接光谱仪接受光谱信号,本实验需使用未连接外泌体的荧光微腔-适体的光谱信号做对照。Step 3: Covalently couple the carboxyl- or amino-modified fluorescent microcavity with an amino- or carboxyl-modified aptamer or specific antibody protein that can specifically bind to the corresponding exosomes. After 2-4 hours, the carboxyl- or amino-modified fluorescent microcavity specifically recognizes the amino- or carboxyl-modified aptamer, and the amino-carboxyl groups are linked together by dehydration condensation reaction; connect the connected microcavity-aptamer to the corresponding cell The extracted exosomes were incubated together for 0.5 hours, and the aptamer specifically recognized and bound to the surface of the corresponding exosomes. Alternatively, a purchased fluorescent microcavity modified with an antibody that specifically recognizes exosome surface antigens was mixed and incubated with exosomes for 0.5 hours. After the successful connection was verified by confocal detection, the microspheres were then irradiated with a laser. The excited fluorescence is coupled into the microsphere to generate laser in the whispering gallery mode, and the external spectrometer receives the spectral signal. In this experiment, the spectral signal of the fluorescent microcavity-aptamer without exosomes is used as a control.

本实验主要应用的是模式移动传感机制即回音壁模式的谐振波长随着环境的变化而变化,而且谐振波长变化越大,说明被检测分子浓度越高;同时,不同的谐振波长对应于不同的检测物质。激光耦合进微腔内部,主要在腔内发生全反射,但是在第二介质(微腔外表面的空气或者液体)仍然存在光场,即倏逝场,分布范围约为微球表面的几百纳米,因此当外泌体结合到微腔表面时,会改变倏逝场,导致频率漂移,又因为微腔的高品质因子Q和窄线宽特性,使得频谱漂移信号被放大,故能够通过光谱仪观察频移来检测特定细胞分泌的外泌体。不同的外泌体对倏逝场的扰动结果不同,则相应的频移也不同,以此来区别不同的外泌体。The main application of this experiment is the mode-shift sensing mechanism, that is, the resonant wavelength of the whispering gallery mode changes with the change of the environment, and the larger the resonant wavelength changes, the higher the concentration of the detected molecules; at the same time, different resonant wavelengths correspond to different test substance. The laser is coupled into the interior of the microcavity, and total reflection occurs mainly in the cavity, but there is still an optical field in the second medium (air or liquid on the outer surface of the microcavity), that is, the evanescent field, with a distribution range of about a few hundred on the surface of the microsphere. nanometer, so when exosomes bind to the surface of the microcavity, it will change the evanescent field, resulting in frequency drift, and because of the high quality factor Q and narrow linewidth characteristics of the microcavity, the spectral drift signal is amplified, so it can pass the spectrometer. Observe the frequency shift to detect exosomes secreted by specific cells. Different exosomes have different perturbation results to the evanescent field, and the corresponding frequency shifts are also different, so as to distinguish different exosomes.

与现有技术相比,本发明具有如下优势:Compared with the prior art, the present invention has the following advantages:

1、检测方法简单,成本低,灵敏度高,可以在细胞外检测细胞内的一些物质。本实验利用激光基于回音壁模式来检测外泌体,使用的聚苯乙烯荧光微球,直径为15μm,具有高品质因子Q和极窄线宽,因此灵敏度较高,且制作成本低;外泌体不但含有多种可以作为标记物的蛋白质,而且细胞分泌的外泌体还包含大量的核酸小分子。该方法高灵敏度可以实现低浓度的检测。1. The detection method is simple, the cost is low, and the sensitivity is high, and some substances in the cell can be detected outside the cell. In this experiment, the laser was used to detect exosomes based on the whispering gallery mode. The polystyrene fluorescent microspheres used were 15 μm in diameter, with high quality factor Q and extremely narrow line width, so the sensitivity was high and the production cost was low; Exosomes not only contain a variety of proteins that can be used as markers, but also exosomes secreted by cells also contain a large number of small nucleic acid molecules. The high sensitivity of this method enables detection of low concentrations.

2.实现在细胞外检测。微球在细胞内作为一个谐振腔,由回音壁模式产生激光输出,充当一个细胞激光器的作用,大量研究表明外泌体可以通过转移致癌蛋白和核酸参与正常的细胞和癌症细胞的发生、生长、进展、转移,那么该细胞激光器便可以实现可跟踪外泌体的运动,在不同的位置实现检测,而且对细胞影响很小,其实用性更强。2. To achieve extracellular detection. The microsphere acts as a resonant cavity in the cell, and the laser output is generated by the whispering gallery mode, acting as a cellular laser. A large number of studies have shown that exosomes can participate in the occurrence, growth, and growth of normal cells and cancer cells by transferring cancer-causing proteins and nucleic acids. Progress and transfer, then the cell laser can track the movement of exosomes, detect at different locations, and have little effect on cells, making it more practical.

3.基于回音壁模式的检测弥补了荧光信号的自吸收和漂白作用,使荧光在腔内形成谐振激发出激光,增强信号强度便于检测,延长了观察与检测时间,增加了检测的可靠性和稳定性。3. The detection based on the whispering gallery mode makes up for the self-absorption and bleaching of the fluorescent signal, so that the fluorescence forms a resonance in the cavity to excite the laser, and the signal intensity is enhanced to facilitate detection, prolong the observation and detection time, and increase the reliability and reliability of detection. stability.

附图说明:Description of drawings:

图1是本发明实验装置结构图说明:1、532nm脉冲激光器;2、衰减片;3、银镜;4、CCD相机;5、聚焦透镜;6、二向色镜;7、 40倍显微物镜;8、样品;9、60倍显微物镜;10、滤波片;11、聚焦透镜;12、传输光纤和探头;13、光谱仪。1 is the structure diagram of the experimental device of the present invention: 1, 532nm pulsed laser; 2, attenuator; 3, silver mirror; 4, CCD camera; 5, focusing lens; 6, dichroic mirror; 7, 40 times microscope Objective lens; 8. Sample; 9. 60x microscope objective lens; 10. Filter; 11. Focusing lens; 12. Transmission fiber and probe; 13. Spectrometer.

具体实施方式Detailed ways

下面结合实施案例对本发明做进一步说明,但本发明并不限于以下实施案例。因为外泌体内含有和细胞内同样的核酸及蛋白质分子,所以我们可以通过对不同种类的细胞进行检测,其中包括各种正常细胞及癌细胞检测相应的microRNA、蛋白质等。The present invention will be further described below in conjunction with the implementation examples, but the present invention is not limited to the following implementation examples. Because exosomes contain the same nucleic acid and protein molecules as cells, we can detect the corresponding microRNAs and proteins by detecting different types of cells, including various normal cells and cancer cells.

实施案例1利用有源微球腔检测乳腺细胞SK-BR3外泌体Example 1 Detection of breast cell SK-BR3 exosomes using active microsphere chambers

本实验选用羧基修饰的聚苯乙烯荧光微球,微球直径为15μm,折射率为n=1.59,具有高Q值和小的模式体积。In this experiment, polystyrene fluorescent microspheres modified with carboxyl groups were selected. The diameter of the microspheres was 15 μm, the refractive index was n=1.59, and the microspheres had a high Q value and a small mode volume.

本实验使用的激光光源为532nm脉冲激光器,不同激光器使用的微球激发波长不同,检测的物质为乳腺细胞SK-BR3分泌的外泌体,首先利用外泌体试剂盒将该乳腺细胞分泌的外泌体提取出来,然后将浓度为0.1kg/L的羧基修饰的聚苯乙烯荧光微球悬浮于MES缓冲液中,加入1-乙基-3-(二甲胺丙基)碳二亚胺溶液和N-羟基琥珀酰亚胺溶液,将浓度为0.5μmol/l的氨基修饰特定序列的适体与羧基修饰的荧光微球混合在室温下搅拌2-4小时,离心清洗后将成功连接适体的荧光微球与提取的外泌体混合在室温下培养0.5个小时,经清洗后首先使用共聚焦检测是否连接成功,再用移液枪取出滴在使用 Poly-D-lysine即多聚赖氨酸清洗过的盖玻片上,最后将载玻片样品置于三维调整架上,调节调整架,使激光自由耦合进微球,增大激光功率至微球的激光激发阈值,将在光谱仪上观察到激光,与只结合适体的微球激发光谱比较,通过光谱移动来确定这种乳腺细胞外泌体的存在。The laser light source used in this experiment is a 532nm pulsed laser. Different lasers use different excitation wavelengths of microspheres. The detected substances are exosomes secreted by breast cells SK-BR3. The exosomes were extracted, and then the carboxyl-modified polystyrene fluorescent microspheres with a concentration of 0.1 kg/L were suspended in MES buffer, and 1-ethyl-3-(dimethylaminopropyl) carbodiimide solution was added. and N-hydroxysuccinimide solution, mix the amino-modified specific sequence aptamer and carboxyl-modified fluorescent microspheres at a concentration of 0.5 μmol/l and stir at room temperature for 2-4 hours. After centrifugation and washing, the aptamer will be successfully connected. The fluorescent microspheres were mixed with the extracted exosomes and incubated at room temperature for 0.5 hours. After washing, confocal was used to check whether the connection was successful, and then the droplets were taken out with a pipette and placed in Poly-D-lysine. On the acid-cleaned cover glass, finally place the slide sample on the three-dimensional adjustment frame, adjust the adjustment frame, make the laser freely couple into the microsphere, increase the laser power to the laser excitation threshold of the microsphere, and observe on the spectrometer To the laser, the presence of such mammary cell exosomes was determined by spectral shift compared to the excitation spectrum of the microspheres bound only with aptamers.

具体实验步骤如下:The specific experimental steps are as follows:

(1)测量羧基修饰的聚苯乙烯荧光微球的光谱。取出浓度为 0.1kg/L的羧基修饰的聚苯乙烯荧光微球,将其悬浮pH=7.4 的PBS缓冲液中摇匀,微球与PBS缓冲液的体积比为1:10,用移液枪将混合后的溶液滴在经过Poly-D-lysine即多聚赖氨酸清洗过的盖玻片,防止微球移动,利用图中装置对羧基修饰的微球进行泵浦,测量激光输出,出现的激光中心峰值在 610nm,记录光谱输出图,作为参考以计算后续实验的频移值。(1) Measure the spectrum of carboxyl-modified polystyrene fluorescent microspheres. Take out the carboxyl-modified polystyrene fluorescent microspheres with a concentration of 0.1kg/L, and suspend them in PBS buffer with pH=7.4 and shake well. The volume ratio of microspheres to PBS buffer is 1:10. The mixed solution was dropped on the coverslip cleaned by Poly-D-lysine, that is, poly-lysine, to prevent the microspheres from moving. The carboxyl-modified microspheres were pumped by the device in the figure, and the laser output was measured. The central peak of the laser is at 610 nm, and the spectral output is recorded as a reference to calculate the frequency shift value for subsequent experiments.

(2)测量连接适体-微球的光谱。首先在离心管中添加下列物质:0.5μmol/l氨基修饰的适体、浓度为0.1kg/L的直径为 15μm的羧基修饰的微球、0.1mol/l 1-乙基-3-(二甲胺丙基) 碳二亚胺溶液简写为EDC、0.1mol/L的N-羟基琥珀酰亚胺溶液简写为NHS,pH=5.5的MES缓冲液,上述物质的体积比为:适体:微球:1-乙基-3-(二甲胺丙基)碳二亚胺溶液:0.1mol/L 的N-羟基琥珀酰亚胺溶液:MES=1:1:5:5:10。在室温条件下旋转搅拌并孵化2-4小时;然后需要离心清洗,离心5分钟,除去上清液,在pH=7.4的PBS缓冲液中重新悬浮;然后离心 5min,除去上清液,最后将颗粒重新悬浮在PBS缓冲液中,获得悬浮液。同样用移液枪将连接好的适体-微球滴加在经过处理的盖玻片上,利用装置图,用532nm激光泵浦适体-微球,测量连接好适体的微球的激光谱,当前浓度下激发的激光中心峰值在609.3nm,发现激光的中心峰值发生了移动。改变加入适体浓度,其他实验条件不变再次进行激发与步骤(1)中的谱图对照,根据谱线的频移,绘制频移-浓度标准曲线。改变加入氨基修饰的特定序列的适体的浓度,测量相应浓度下的激光光谱图,根据回音壁检测物质的原理,产生频移最大时,说明适体的结合效率最高,所以可以计算测定最佳适体连接效率。(2) Measure the spectrum of the linked aptamer-microsphere. First, add the following substances to the centrifuge tube: 0.5 μmol/l amino-modified aptamer, 0.1 kg/L carboxyl-modified microspheres with a diameter of 15 μm, 0.1 mol/l 1-ethyl-3-(dimethylformaldehyde) Aminopropyl) carbodiimide solution is abbreviated as EDC, 0.1mol/L N-hydroxysuccinimide solution is abbreviated as NHS, pH=5.5 MES buffer, the volume ratio of the above substances is: aptamer: microsphere : 1-ethyl-3-(dimethylaminopropyl) carbodiimide solution: 0.1 mol/L N-hydroxysuccinimide solution: MES=1:1:5:5:10. Rotate and incubate for 2-4 hours at room temperature; then need to centrifuge for washing, centrifuge for 5 minutes, remove the supernatant, and resuspend in PBS buffer pH=7.4; then centrifuge for 5 minutes, remove the supernatant, and finally The particles were resuspended in PBS buffer to obtain a suspension. Similarly, drop the connected aptamer-microspheres on the treated coverslip with a pipette, use the device diagram to pump the aptamer-microspheres with a 532nm laser, and measure the laser spectrum of the aptamer-connected microspheres , the central peak of the laser excited at the current concentration is 609.3 nm, and it is found that the central peak of the laser has shifted. Change the concentration of the added aptamer, and perform excitation again with other experimental conditions unchanged to compare with the spectrum in step (1), and draw a frequency shift-concentration standard curve according to the frequency shift of the spectrum line. Change the concentration of the amino-modified aptamer with a specific sequence, and measure the laser spectrum at the corresponding concentration. According to the principle of the whispering gallery detection substance, when the frequency shift is the largest, it indicates that the aptamer has the highest binding efficiency, so it can be calculated and determined as the best Aptamer ligation efficiency.

(3)测定特定外泌体的存在。首先使用无外泌体的血清培养该乳腺细胞,然后用外泌体试剂盒提取出细胞分泌的外泌体;将连接好的适体-微球与提取出的外泌体一起孵育0.5个小时,用移液枪滴加在经过Poly-D-lysine即多聚赖氨酸清洗过的盖玻片上,利用装置图在532nm激光泵浦下,记录激光激发光谱,当前激光的中心峰值为607.6nm,与(2)参考谱对比,发现激光的中心峰值发生了移动,由此根据测量的频移,测定该外泌体的存在。(3) Determination of the presence of specific exosomes. The mammary gland cells were first cultured with exosome-free serum, and then the exosomes secreted by the cells were extracted with an exosome kit; the connected aptamer-microspheres were incubated with the extracted exosomes for 0.5 hours , drop it on the cover glass cleaned by Poly-D-lysine (poly-lysine) with a pipette, record the laser excitation spectrum under 532nm laser pumping using the device diagram, the current central peak of the laser is 607.6nm , compared with the reference spectrum in (2), it was found that the central peak of the laser was shifted, and the presence of the exosome was determined according to the measured frequency shift.

(4)实验结果,可以快速灵敏的在细胞外实现对细胞内物质的检测。(4) As a result of the experiment, the detection of intracellular substances can be quickly and sensitively realized outside the cell.

实施案例2利用有源微球腔检测前列腺细胞分泌的外泌体上的生物大分子的前列腺特异性抗原即PSAExample 2 Using the active microsphere cavity to detect the prostate-specific antigen (PSA) of biological macromolecules on exosomes secreted by prostate cells

目前对于前列腺特异性抗原的检测主要是侵入性的,包括通过直肠指检检查、经直肠超声引导的活组织检查等。利用有源腔对外泌体进行检测,具有非侵入性的优势,同时对PSA测量更加方便快速,本发明的研究内容为利用特定适体修饰的有源微球对前列腺细胞分泌的外泌体中的PSA进行检测。Currently, the detection of PSA is mainly invasive, including by digital rectal examination, transrectal ultrasound-guided biopsy, etc. The use of active cavity to detect exosomes has the advantages of non-invasiveness, and it is more convenient and fast to measure PSA. The research content of the present invention is to use specific aptamer-modified active microspheres to detect exosomes secreted by prostate cells. PSA was detected.

具体实验步骤如下:The specific experimental steps are as follows:

(1)首先购买羧基修饰的荧光微球;(1) First purchase carboxyl-modified fluorescent microspheres;

(2)需要修饰的适体,适体序列为5’-TTATTAAAGCTCGCCATCAAA TAGC-3’-NH2,与羧基修饰的微球,根据公式S=(6/ρSd)·C计算求出所需适体浓度,其中S是单层修饰需要的适体的量(mg适体/g微球),ρS是微球的密度(g/cm3),d是微球的直径,C 是微球表面的容量。(2) The aptamer to be modified, the aptamer sequence is 5'-TTATTAAAGCTCGCCATCAAA TAGC-3'-NH2, and the carboxyl group-modified microsphere, according to the formula S=(6/ρSd)·C to calculate the required aptamer concentration , where S is the amount of aptamer required for monolayer modification (mg aptamer/g microsphere), ρS is the density of the microsphere (g/cm 3 ), d is the diameter of the microsphere, and C is the capacity of the microsphere surface .

(3)先将羧基修饰的微球置于pH=5.5的MES溶液中,再加入 EDC和NHS,使其在适宜的环境中活化羧基。然后加入适体,经过涡旋振荡离心清洗得到连接适体成功的荧光微球。(3) The carboxyl group-modified microspheres were placed in MES solution with pH=5.5, and then EDC and NHS were added to activate the carboxyl group in a suitable environment. Then, the aptamer was added, and the fluorescent microspheres successfully connected to the aptamer were obtained by vortexing and centrifugal washing.

(4)提取纯化外泌体,先使用正常含有外泌体的牛血清培养该类前列腺细胞,生长状态良好,细胞数目至视野范围内70%-80%时,使用无外泌体牛血清进行传代培养,生长状态良好,细胞数目至视野范围内70%-80%时,使用试剂盒进行提取纯化。(4) Extract and purify exosomes, first use bovine serum containing normal exosomes to culture the prostate cells, the growth state is good, and when the number of cells reaches 70%-80% within the field of view, use bovine serum without exosomes to carry out Subculture, the growth state is good, and when the number of cells reaches 70%-80% within the field of view, use a kit for extraction and purification.

(5)将成功连接适体的荧光微球与提取纯化得到的外泌体放在一起混合孵育培养0.5个小时,使用共聚焦验证连接成功。(5) The fluorescent microspheres successfully connected to the aptamer and the extracted and purified exosomes were mixed together and incubated for 0.5 hours, and the successful connection was verified by confocal.

(6)在532nm脉冲激光器的泵浦下,记录激光光谱,通过与修饰羧基的微球、成功连接适体的微球的光谱图进行比较,发现修饰羧基的微球、成功连接适体的微球以及成功连接外泌体的微球三者的激光光谱依次发生了位移,当连接样品中的外泌体浓度不同时,激光谱的中心峰值相比于成功连接适体的激光谱的中心峰值,移动的位移大小也不同。由此可以利用光谱的频移来观察PAS 的存在,以及浓度变化。(6) Under the pumping of a 532nm pulsed laser, record the laser spectrum, and compare with the spectra of the carboxyl-modified microspheres and the aptamer-connected microspheres, and found that the carboxyl-modified microspheres and the aptamer-connected microspheres were successfully The laser spectra of the spheres and the microspheres successfully connected to exosomes shifted sequentially. When the concentrations of exosomes in the connected samples were different, the central peak of the laser spectrum was compared with the central peak of the laser spectrum of the successfully connected aptamer. , the displacement size of the movement is also different. From this, the frequency shift of the spectrum can be used to observe the presence of PAS, as well as the change in concentration.

(7)实验结果,使用该方法检测可以达到一个快速高效的检测效果。(7) Experimental results, using this method to detect can achieve a fast and efficient detection effect.

实施案例3利用有源微球腔检测胰腺导管细胞分泌的外泌体中的磷脂酰肌醇蛋白聚糖-1简写为GPC-1Example 3 Detection of Glypican-1 in exosomes secreted by pancreatic ductal cells using the active microsphere cavity

目前有关于胰腺导管细胞的相关检测手段主要是昂贵的成像研究,例如计算机断层扫描(CT)、磁共振成像(MRI)和内窥镜超声等。最近磷脂酰肌醇蛋白聚糖-1(glypican-1)已被鉴定为外泌体的生物标记物。本发明基于外泌体标记物glypican-1,利用羧基修饰的荧光微球与氨基修饰的识别GPC-1的抗体识别并通过氨基羧基的共价偶联结合,然后与外泌体混合,会与外泌体表面的标记物GPC-1发生抗原抗体特异性识别并结合,使得此时的激光的发射光谱与未识别结合外泌体的羧基修饰的微腔的激光发射谱相比发生移动,识别的外泌体浓度越大产生的位移也就越大,因此可以通过光谱位移的大小实现对该物质的浓度检测。Currently, the relevant detection methods for pancreatic ductal cells are mainly expensive imaging studies, such as computed tomography (CT), magnetic resonance imaging (MRI), and endoscopic ultrasound. Glypican-1 has recently been identified as a biomarker for exosomes. The present invention is based on the exosome marker glypican-1, uses carboxyl-modified fluorescent microspheres and amino-modified GPC-1-recognizing antibodies to recognize and bind through the covalent coupling of amino carboxyl groups, and then mixes with exosomes, which will be combined with exosomes. The marker GPC-1 on the surface of exosomes is specifically recognized and bound by antigen and antibody, so that the emission spectrum of the laser at this time is shifted compared with the laser emission spectrum of the carboxyl-modified microcavity that does not recognize the exosome binding. The greater the concentration of exosomes, the greater the shift will be, so the concentration of the substance can be detected by the magnitude of the spectral shift.

具体实验步骤如下:The specific experimental steps are as follows:

(1)首先购买带有羧基修饰的荧光微球:(1) First buy fluorescent microspheres with carboxyl group modification:

a)加入pH=5.5的MES溶液和1-乙基-3-(二甲胺丙基)碳二亚胺)溶液、N-羟基琥珀酰亚胺溶液,活化羧基修饰的荧光微球;a) adding pH=5.5 MES solution, 1-ethyl-3-(dimethylaminopropyl) carbodiimide) solution and N-hydroxysuccinimide solution to activate carboxyl-modified fluorescent microspheres;

b)羧基修饰的微球与氨基修饰的识别GPC-1的抗体结合。b) Carboxyl-modified microspheres bind to amino-modified GPC-1-recognizing antibodies.

(2)培养胰腺细胞U87-MG,生长状态良好时,采用试剂盒提取外泌体。(2) The pancreatic cells U87-MG were cultured, and the kit was used to extract exosomes when the growth state was good.

(3)将连接特异性抗体的荧光微球与外泌体一起孵育0.5个小时,并清洗后,使用532nm脉冲激光器分别对羧基修饰的微球、连接特异性抗体的微球、与不同浓度的外泌体结合的微球分别泵浦,依次得到三个激光光谱数据,通过比较三次激发的激光光谱的中心峰值,发现激光中心峰值的波长会依次发生位移,并且在制作样品时改变适体的浓度和提取的外泌体浓度,激光中心峰值的移动的大小也会相应的改变。(3) The fluorescent microspheres linked to specific antibodies were incubated with exosomes for 0.5 hours, and after washing, the carboxyl-modified microspheres, the microspheres linked to specific antibodies, and different concentrations of The exosome-bound microspheres were pumped separately, and three laser spectrum data were obtained in turn. By comparing the central peaks of the three-excited laser spectra, it was found that the wavelength of the central laser peak would shift in sequence, and the aptamer was changed during sample preparation. The concentration and the concentration of extracted exosomes, the magnitude of the shift of the laser center peak will also change accordingly.

(4)根据输出的光谱频移图来鉴定GPC-1的存在和浓度大小。(4) Identify the presence and concentration of GPC-1 according to the output spectral frequency shift map.

本发明的核心部分在于激光激发回音壁模式,实现细胞外激光输出,当被修饰的有源荧光微球与抗体或者适体的特异性结合时,发生光谱频率的偏移,从而实现高灵敏度的细胞外物质检测。The core part of the present invention lies in the laser excitation of the whispering gallery mode to achieve extracellular laser output. When the modified active fluorescent microspheres are specifically combined with antibodies or aptamers, spectral frequency shift occurs, thereby achieving high sensitivity. Extracellular material detection.

Claims (7)

1. A method for detecting exosomes based on whispering gallery mode optical microcavities is characterized by comprising the following specific steps:
step 1: a detection device is set up, a nano pulse laser is fixed on an optical platform, so that a transmitted beam is emitted horizontally, the beam passes through an attenuation sheet and is used for adjusting the light intensity emitted to the surface of a sample, then passes through a silver mirror, the beam path is changed into a right angle with the original direction, the purpose is to increase the setting up of a rear light path in the setting up space, a dichroic mirror is added along the beam direction, so that the reflected beam is parallel to the original beam, a 40-time microscope objective is fixed along the reflected beam direction, the beam is collimated to pass through, then a 60-time microscope objective is fixed behind the 40-time objective along the beam direction, the distance between the two microscope objectives is the sum of the focal distances of the two objectives, namely the focal points are overlapped, in the experimental process, a sample is placed at the focal point overlapped part of the two objectives and is used for exciting a microcavity, then a filter is fixed, a focusing lens is fixed behind the filter plate and used for collecting fluorescence and laser and transmitting the fluorescence and the laser to a receiver optical fiber probe of a spectrometer behind the focusing lens more efficiently; a focusing lens is fixed behind the focusing lens along the direction of the transmitted light beam and is used for displaying an image on a CCD camera behind and observing the condition that the light beam acts on the surface of the microcavity;
step 2: the laser is incident into the echo wall micro-cavity with the size of several to dozens of microns, and is totally reflected inside the micro-cavity doped with the fluorescent material, when the total reflection optical path is integral multiple of the wavelength, the total reflection optical path forms a resonant cavity, and when the light meets the condition that the gain is greater than the loss, a whispering gallery mode micro-cavity for detection is formed;
step 2: the method comprises the following steps of treating the echo wall microcavity of which the surface is modified with carboxyl or amino and is doped with fluorescent substances, wherein the step is mainly to mix and react an aptamer modified with amino or carboxyl or specific antibody protein modified with amino or carboxyl with the corresponding echo wall microcavity modified with surface carboxyl or amino, and the target detection object and a modifier on the surface of the microcavity are identified and combined through automatic covalent coupling of amino and carboxyl;
and step 3: incubating the echo wall microcavity connected with the aptamer or the specific antibody protein with the exosome, and specifically identifying and combining the aptamer or the specific antibody protein successfully connected with the microcavity surface and the specific protein on the corresponding exosome surface by base complementary pairing;
and 4, irradiating the microcavity with a laser, centrifuging after the exosome is successfully connected with the microcavity, washing off the exosome and the microcavity which are not successfully connected, suspending the exosome and the microcavity in PBS (phosphate buffer solution) with the pH value of 7.4, dripping the microcavity successfully connected with the exosome on a glass slide, putting the glass slide in a light path, focusing and coupling laser beams into the microcavity by adjusting the position of the glass slide, firstly, adjusting the intensity of the light beams by using an attenuation sheet to enable the light beams to reach an ASE (amplified spontaneous emission) signal for exciting fluorescence at an excitation threshold, then, rotating the attenuation sheet to enable the light power emitted to the surface of the microcavity to increase the light intensity by increasing the light power of 5 muW each time, enabling the light beams to emit laser in a whispering gallery mode, externally connecting a spectrometer and a CCD (charge coupled device) and combining the microcavity and the exosome.
2. The detection method according to claim 1, wherein the fluorescent substance is a fluorescent dye, a quantum dot, or a fluorescent protein.
3. The detection method as claimed in claim 1, wherein the surface treatment comprises specific antibody protein modification or related detection aptamer modification.
4. The detection method of claim 1, wherein the echo wall microcavity material is selected from the group consisting of: the surface is modified with carboxyl or amino micro-cavity.
5. The detection method according to claim 1, wherein the selection of the laser light source: the nano pulse laser detects the cell secretion exosome produced by various cells.
6. The detection method according to claim 1, wherein the exosome molecules in the culture solution are detected first, and purchased microcavities with the surface modified by carboxyl or amino groups and the mass concentration of 0.1kg/L are arranged in a proportion of 1: adding MES buffer solution according to the volume ratio of 10, centrifuging, shaking, washing, then resuspending in the MES buffer solution, wherein the pH value of the MES buffer solution is 5.5, adding 1-ethyl-3- (dimethylaminopropyl) carbodiimide solution with the concentration of 0.1mol/L according to the volume ratio of 1:5 of the microcavity and 1-ethyl-3- (dimethylaminopropyl) carbodiimide solution, then adding N-hydroxysuccinimide solution with the concentration of 0.1mol/L according to the volume ratio of 1:5 of the microcavity and the N-hydroxysuccinimide solution, so that the carboxyl group on the surface modification of the microcavity promotes the recognition and the combination with the amino group modified aptamer and the amino group modified specific antibody protein, or the carboxyl group on one end of the carboxyl group modified aptamer and the carboxyl group modified specific antibody protein promotes the recognition and the combination with the amino group modified microcavity, and mixing uniformly, adding amino-group or carboxyl-group modified aptamer or specific antibody protein into a microcavity the surface of which is modified by carboxyl or amino-group and an amino-group or carboxyl-group modified aptamer or specific antibody protein according to the volume ratio of 1:1, performing vortex oscillation for 3 hours, performing dehydration condensation on the amino-group and the carboxyl group to realize connection of the aptamer or specific antibody protein and the microcavity, centrifuging for 5min, washing off redundant aptamer, and resuspending the centrifuged sample in PBS buffer according to the volume ratio of the microcavity to the PBS buffer of 1: 8; then uniformly mixing a connecting body microcavity-aptamer or microcavity-specific antibody protein re-suspended in a PBS buffer solution with exosome molecules with the concentration of 0.5 mu mol/l according to the volume ratio of 1:1, realizing specific recognition and combination of the microcavity and the exosome molecules through the specific combination characteristic of the protein, centrifuging for 5min through a centrifuge after mixing and incubation, and re-adding the PBS buffer solution with the pH value of 7.4; then placing the PBS buffer solution containing the mixture microcavity, the aptamer or the specific antibody protein, the exosome and the microcavity-aptamer-exosome in a centrifuge tube, centrifuging for 5min, and then resuspending in the PBS buffer solution for storage;
taking out the culture solution successfully connected by using a pipette and dripping the culture solution on a cover glass to manufacture a glass slide; finally, laser is focused and coupled into the micro-cavity, a CCD camera is used for imaging to observe and adjust light beams to focus the light beams on a single micro-cavity, the spectral positions before and after the connection with the exosome are compared and analyzed through spectral recording on a spectrometer, and the existence of the exosome is judged by finding the movement of the front and back comparison spectra; and comparing and analyzing the spectral shift generated by the exosomes secreted by different cells to judge the types of the cells.
7. The method for detecting exosomes according to claim 1, wherein the specific experimental steps for detecting exosomes secreted by cells are as follows:
(1) firstly, connecting a purchased amino or carboxyl modified aptamer with a purchased carboxyl or amino modified fluorescent microsphere, and calculating the quantity concentration and volume of substances of the amino or carboxyl modified aptamer corresponding to the connection of the carboxyl or amino modified microsphere according to the principle that the amino and the carboxyl are connected in a dehydration condensation manner according to the quantity ratio of 1: 1;
(2) the purchased fluorescent microspheres with the surfaces modified by carboxyl or amino are mixed according to the ratio of 1: adding MES buffer solution according to the volume ratio of 10, centrifuging by a centrifuge, shaking for 5 minutes, washing, and then resuspending in the MES buffer solution, wherein the pH value of the MES buffer solution is 5.5; the following were then added to the centrifuge tube: 0.5 mu mol/L of aptamer with a base sequence capable of identifying secretion exosomes of cells to be detected, wherein one end of the aptamer is modified with amino or carboxyl, 0.1mol/L of 1-ethyl-3- (dimethylaminopropyl) carbodiimide solution and 0.1mol/L of N-hydroxysuccinimide solution; the volume ratio of the fluorescent microsphere modified by carboxyl or amino is as follows: fluorescent microsphere, aptamer, 1-ethyl-3- (dimethylaminopropyl) carbodiimide solution and N-hydroxysuccinimide solution, wherein the aptamer is 1:1:5
(3) Rotationally stirring and incubating for 3 hours at room temperature, then centrifugally washing, centrifuging for 5 minutes, removing supernatant, washing out 1-ethyl-3- (dimethylaminopropyl) carbodiimide, N-hydroxysuccinimide and unsuccessfully connected aptamer and microsphere, then adding PBS buffer solution with the pH value of 7.4, and suspending the fluorescent microcavity successfully connected with the specific base sequence in the PBS buffer solution;
(4) putting the suspension into a centrifuge tube, centrifuging for 5min, removing supernatant, adding PBS buffer solution to resuspend the exosome-aptamer-microsphere connecting body in the PBS buffer solution for storage;
(5) culturing the mammary cells for 48 hours by using the exosome-free serum, and extracting exosomes by using an exosome extraction kit;
(6) adding a buffer solution with the pH value of 7.4 into the extracted exosome to dilute the exosome into different concentrations;
(7) exosomes of different concentrations were mixed with sample solutions of exosome-aptamer-microsphere linkers suspended in PBS buffer at 1:1, evenly mixing and incubating for 0.5 hour;
(8) centrifuging the sample solution after the seventh step reaction in a centrifuge for 5min, washing twice, and then resuspending in a buffer solution of PBS (phosphate buffer solution) with the pH value of 7.4;
dripping the successfully connected exosome-aptamer-fluorescent microspheres on a cover glass cleaned by using Poly-D-lysine (polylysine) by using a pipette gun, exciting the exosome-aptamer-microspheres by using a 532nm pulse laser, measuring and recording an excitation spectrum of the exosome-aptamer-microspheres, comparing the excitation spectrum with an excitation spectrogram of the aptamer-fluorescent microspheres, measuring the frequency shift of a spectral line, and drawing a frequency shift-concentration standard curve;
because need use the spectrum appearance to detect the spectrum, so need go on under the shading condition, in order to guarantee the life of the optical system who builds, need guarantee indoor cleanness simultaneously.
CN202010526595.XA 2020-06-10 2020-06-10 An exosome detection method based on whispering gallery mode optical microcavity Pending CN111999270A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010526595.XA CN111999270A (en) 2020-06-10 2020-06-10 An exosome detection method based on whispering gallery mode optical microcavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010526595.XA CN111999270A (en) 2020-06-10 2020-06-10 An exosome detection method based on whispering gallery mode optical microcavity

Publications (1)

Publication Number Publication Date
CN111999270A true CN111999270A (en) 2020-11-27

Family

ID=73467861

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010526595.XA Pending CN111999270A (en) 2020-06-10 2020-06-10 An exosome detection method based on whispering gallery mode optical microcavity

Country Status (1)

Country Link
CN (1) CN111999270A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113358618A (en) * 2021-06-04 2021-09-07 南京鼓楼医院 Exosome capturing method based on surface multi-thorn coding microspheres
CN118443579A (en) * 2024-04-25 2024-08-06 首都医科大学附属北京友谊医院 Method for establishing cancer diagnosis model based on optical signals and application

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101027546A (en) * 2004-05-26 2007-08-29 杰纳罗生物系统有限公司 Biosensor using whispering gallery modes in microspheres
CN102272597A (en) * 2008-11-21 2011-12-07 惠研生物系统公司 Analyte detection test
CN105452466A (en) * 2012-10-23 2016-03-30 卡里斯生命科学瑞士控股有限责任公司 Aptamers and uses thereof
CN108593916A (en) * 2018-04-08 2018-09-28 国家纳米科学中心 Cancer detection system and method based on excretion body
CN108760704A (en) * 2018-06-01 2018-11-06 北京工业大学 A kind of unicellular interior substance detecting method based on Whispering-gallery-mode
CN109507162A (en) * 2018-12-11 2019-03-22 北京工业大学 A kind of laser detection system and method based on resonant cavity and FRET effect
CN110320260A (en) * 2019-07-27 2019-10-11 福建师范大学 The excretion body Electrochemiluminescsensor sensor enhanced based on MXenes and black phosphorus quantum dot

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101027546A (en) * 2004-05-26 2007-08-29 杰纳罗生物系统有限公司 Biosensor using whispering gallery modes in microspheres
CN102272597A (en) * 2008-11-21 2011-12-07 惠研生物系统公司 Analyte detection test
CN105452466A (en) * 2012-10-23 2016-03-30 卡里斯生命科学瑞士控股有限责任公司 Aptamers and uses thereof
CN108593916A (en) * 2018-04-08 2018-09-28 国家纳米科学中心 Cancer detection system and method based on excretion body
CN108760704A (en) * 2018-06-01 2018-11-06 北京工业大学 A kind of unicellular interior substance detecting method based on Whispering-gallery-mode
CN109507162A (en) * 2018-12-11 2019-03-22 北京工业大学 A kind of laser detection system and method based on resonant cavity and FRET effect
CN110320260A (en) * 2019-07-27 2019-10-11 福建师范大学 The excretion body Electrochemiluminescsensor sensor enhanced based on MXenes and black phosphorus quantum dot

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YU AN: "magneto-mediated electrochemical sensor for simultaneous analysis of breast cancer exosomal proteins" *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113358618A (en) * 2021-06-04 2021-09-07 南京鼓楼医院 Exosome capturing method based on surface multi-thorn coding microspheres
CN118443579A (en) * 2024-04-25 2024-08-06 首都医科大学附属北京友谊医院 Method for establishing cancer diagnosis model based on optical signals and application

Similar Documents

Publication Publication Date Title
Humar et al. Intracellular microlasers
CN106959370B (en) A kind of biological sensor and detection method based on coupling grating
JP5301894B2 (en) Detection method
JP6112173B2 (en) Fluorescent label for tissue staining and biological material detection method
US20090304551A1 (en) Ultra Sensitive Tapered Fiber Optic Biosensor For Pathogens, Proteins, and DNA
JP5160985B2 (en) Detection method, detection apparatus, detection sample cell, and detection kit
CN100470279C (en) All-fiber evanescent wave biosensor
CN111999270A (en) An exosome detection method based on whispering gallery mode optical microcavity
CN108760704A (en) A kind of unicellular interior substance detecting method based on Whispering-gallery-mode
JP2010019767A (en) Detection method, detector, detecting sample cell, and detecting kit
US9335324B2 (en) Assay method and kit for assay employing sensor chip for fluorescent measuring apparatus utilizing surface plasmon-field enhanced fluorescence spectrometry
JP5958339B2 (en) Near-field enhanced fluorescence sensor chip
JP6743703B2 (en) Immunostaining method and immunostaining reagent kit used therefor
US20120165646A1 (en) Composite particle, contrast agent for photoacoustic imaging, and photoacoustic imaging method
JP2013096707A (en) Sensing unit, sensing device equipped with the same and method for detection of target object
Zhang et al. Optofluidic lasers and their applications in biochemical sensing
Su et al. High-contrast luminescent immunohistochemistry using PEGylated lanthanide complexes
CN108802008A (en) A kind of method and apparatus detecting tumour cell in blood using stimlated Raman spectrum
AU2012255683B2 (en) A method of and a system for characterising a material
Eenink et al. Fibre-fluorescence immunosensor based on evanescent wave detection
KR102267198B1 (en) Optical bio-sensor for bio-material analysis using upconversion nanoparticle, and bio-material quantitative analysis using the same
JP5754309B2 (en) Quantitative analysis method for measuring fluorescence using surface plasmon excitation enhanced fluorescence spectroscopy, and quantitative analysis kit and analyte dissociation inhibitor used therefor
RU2799016C1 (en) Method of detecting local temperature in living cells and constructing temperature map of living cells
CN109374893A (en) Detection system and method of PD-L1 receptor based on thermophoresis
JP2020071152A (en) Method for immunostaining, system for immunostaining, and immunostaining kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20201127

WD01 Invention patent application deemed withdrawn after publication